期刊文献+

中药复方AK粗提物协同顺铂抗结肠癌动物模型研究 被引量:2

Experimental study on anti-colorectal cancer efficacy of extracts of TCM Compound AK combined with cisplatin
原文传递
导出
摘要 目的:探讨中药复方AK粗提物对化疗药物顺铂的减毒增效作用。方法:建立BALB/c小鼠CT-26结肠腺癌动物模型,随机分为6组,A组为对照组,B组为单用顺铂组,C组为单用AK组,D、E和F组为协同实验组。建模24h后进行干预,连续用药12d。第14d处死小鼠,观察抑瘤率、血常规、胸腺指数、脾脏指数、肝肾功能,流式细胞术检测外周血T细胞亚群,显微镜下观察移植瘤和肾组织的变化。结果:①与对照组比较,D、E、F各实验组瘤重明显降低(P<0.05);B、C、D、E、F各组抑瘤率分别为55.92%、28.11%、61.05%、71.11%、69.72%,协同实验组抑瘤率明显增高。②与对照组比较,B组的白细胞、血小板数量降低,BUN升高(P<0.01);与B组比较,D、E、F组白细胞、血小板数量升高,BUN降低(P<0.01)。③与对照组比较,B组CD3+、CD4+、CD4+/CD8+比值明显降低,CD8+值升高(P<0.05);与B组比较,D、E、F组CD3+、CD4+、CD4+/CD8+值有所提高,CD8+值降低(P<0.01)。④与对照组比较,B组小鼠胸腺指数和脾脏指数明显降低(P<0.05);D、E、F组的小鼠胸腺指数和脾脏指数均高于B组(P<0.05)。结论:中药复方AK粗提物对顺铂具有减毒增效的作用。 Objective:To investigate the toxicity-reducing and synergistic effects of the extracts of AK prescription for chemotherapy.Methods:Models of colorectal CT-26 tumor bearing mice were established and randomly divided into six groups,including group A(control group),group B(CDDP group),group C(AK group) and combined treatment groups D,E and F.The medication was begun after 24 hours since inoculation,once a day for 12 days.Mice were sacrificed on day 14th.The tumor inhibitory rate,thymus index,spleen index,liver and renal function and the blood cell in the peripheral blood were measured.The subtypes of T lymphocytes in the peripheral blood were detected by flow cytometry.Optical microscopy was employed to observe the structure of tumor and renal.Results:①The tumor weight in groups D,E and F was lighter than that in group A(P0.05).Groups B,C,D,E and F could inhibit the tumor growth and the tumor inhibition rate was 55.92%,28.11%,61.05%,71.11%,69.72%,respectively.②Compared with group A,in group B the count of WBC and PLT was decreased obviously and the level of blood urea nitrogen(BUN) was increased(P0.01).Compared with group B,in groups D,E and F the count of WBC and PLT was increased and the level of BUN was decreased(P0.01).③Compared with group A,in group B the level of CD3+,CD4+,CD4+/CD+8 was lower and the level of CD+8 was higher(P0.05).The level of CD3+,CD4+,CD4+/CD+8 in groups D,E and F,was higher than that in group B,but CD+8 value was decreased(P0.01).④Compared with group A,thymus index and spleen index were decreased in group B(P0.05).Groups D,E and F had different levels ofincrease in thymus index and spleen index compared with group B(P0.05).Conclusion:The extracts of prescription of TCM AK can display the toxicity-reducing and synergistic effects for chemotherapy.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2010年第10期1666-1669,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 云南省卫生厅专项基金(No.2009NS035) 云南省科技厅-昆明医学院联合专项基金(No.2007C0024R)~~
关键词 AK方粗提物 顺铂 结肠癌 动物模型 减毒增效 The extracts of AK prescription CDDP Colorectal cancer Animal model Toxicity-reducing and Synergistic effects
  • 相关文献

参考文献14

  • 1赵国平,戴慎,陈仁寿.中药大辞典.上海:上海科学技术出版社,2001:2459-2460.
  • 2Sartippour M R,Liu C,Shao Z M,et al.Livistona extract inhabits angiogenesis and cancer growth.Oncol Rep,2001,8(6):1355-1357.
  • 3Cheung S,Tai J.In vitro studies of the dry fruit of Chinese fan palm Livistona chinensis.Oncol Rep,2005,14(5):1331-1336.
  • 4Liu S Y,Hsu C C,Ho IC.Antitumor metastatic components in Trap a taiw an-ensis (Nakai) and Livistona chinensis R.Br.Ball Inst Zool Acad Sin, 1987,26(2):143-150.
  • 5陆瑞利,胡丰林,许成林.一些单子叶木本植物鲜叶提取物清除DPPH自由基活性初探[J].生物学杂志,2003,20(6):37-39. 被引量:9
  • 6周韵丽 黄丽瑛 等.云南美登木中美登素和美登普林的分离和鉴定[J].科学通报,1980,25:427-427.
  • 7潘国凤,杨庆,刘安,温小刚,李玉洁,董宇,朱晓新.瑞香狼毒药效组分抑制小鼠皮下移植瘤H22的实验研究[J].中华中医药杂志,2009,24(4):438-442. 被引量:9
  • 8王阶,郭丽丽,王永炎.中药方剂有效成(组)分配伍研究[J].中国中药杂志,2006,31(1):5-9. 被引量:77
  • 9Diederichsen A C,Hjelmborg J B,Christensen P B,et al .Prognostic value of the CD4/CD8 ratio of tumottr infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother,2003,52(7):423 -428.
  • 10Shelly T M,Asher O,Michael L.Review of the potential effects of three commonly used antineoplastic and immunosuppressive rugs(cyclophosphamide,azathioprine,doxorubicin on the embryo and placenta).Reprod Toxicol,2004,18(2):219-230.

二级参考文献19

共引文献96

同被引文献27

  • 1Jemal A, Siegel H. Ward K, et al. Cancer slatislios, 2009. CA Cancer JClin, 2009, 59(4):225-249.
  • 2Saif M W, Lansigan F,Ruta S, et al. Phase I study of the botanicalformulation PHY906 with capecitabine in advanced pancreatic and othergastrointestinal malignancies. Phytomedicine, 2010, 17(3-4):161-169.
  • 3Kummar S, Copur M S, Rose M, et al. A phase I study of the Chineseherbal medioine PHY906 as a modulator of irinotecan-basedchemotherapy in patients with advanced colorectal cancer. ClinColorectal Cancer, 2011, 10(2):85-96.
  • 4Zhu Z, Li E, Liu Y, et al. Inhibition of Jak-STAT3 pathway enhancesbufalin—induced apoptosis in colon cancer SW620 cells. World J SurgOncol, 2012,10(1):1-8.
  • 5Micheau 0,Tschopp J. Induction of TNF receptor I-mediated apoptosisvia two sequential signaling complexes. Cell, 2003,114(2):181-190.
  • 6Holler N, Zaru R, Micheau 0,et al. Fas triggers an alternative,caspase-8-independent cell death pathway using the kinase RIP aseffector molecule. Nat Immunol, 2000, 1(6):489-495.
  • 7Zhang Y, Goodyer C, LeBlanc A. Selective and protracted apoptosis inhuman primary neurons microinjection with active caspase-3, -6, -7and -UNeuresci,2000,20(22):8384-8389.
  • 8Shang X F, He X,He X Y, et al. The genus Scutellaria ethnophar-macological and phytochemical review. Journal Ethnopharmacol,2010,128(2):279-313.
  • 9宋旦哥,孟庆刚.黄芩药理作用研究述评[J].中华中医药学刊,2009,27(8):1619-1622. 被引量:52
  • 10李玉东,刁勇,王立强.芍药及其有效成分抗肿瘤作用的研究进展[J].海峡药学,2009,21(12):27-32. 被引量:17

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部